Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice

Cardiovascular Research

Volumn 82, Issue 1, 2009, Pages 107-114

  Czibik, Gabor ^a   Sagave, Julia ^a   Martinov, Vladimir ^a   Ishaq, Bushra ^a   Sohl, Marcus ^b   Sefland, Iren ^a   Carlsen, Harald ^a   Farnebo, Filip ^b   Blomhoff, Rune ^a   Valen, Guro ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cardioprotection; Gene delivery; Haem oxygenase; Hypoxia inducible factor 1 alpha; Myocardial infarction

Indexed keywords

DEUTEROPORPHYRIN DERIVATIVE; HEME; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; OXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; ENZYME INHIBITION; GENE TARGETING; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEME SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; SKELETAL MUSCLE; STAINING;

ANIMALS; BILIRUBIN; CELL LINE; CELL SURVIVAL; DEUTEROPORPHYRINS; DISEASE MODELS, ANIMAL; ELECTROPORATION; ENZYME INHIBITORS; GENE THERAPY; HEME OXYGENASE-1; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; ORGANOMETALLIC COMPOUNDS; OXIDANTS; QUADRICEPS MUSCLE; TIME FACTORS; TRANSFECTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 62349099936     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp035     Document Type: Article

References (27)

1. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. Faseb J 2002;16:1151-1162.
2. Shyu KG, Wang MT, Wang BW, Chang CC, Leu JG, Kuan P et al. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 2002;54:576-583.
3. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 2005;46:2116-2124.
4. Czibik G, Martinov V, Ruusalepp A, Sagave J, Skare Ø, Valen G. In vivo remote delivery of DNA encoding for hypoxia-inducible factor 1 alpha reduces myocardial infarct size. Clin Transl Sci 2009; Epub ahead of print 31 January 2009.
5. Shu E, Matsuno H, Akamastu S, Kanno Y, Suga H, Nakajima K et al. alphaB-crystallin is phosphorylated during myocardial infarction: involvement of platelet-derived growth factor-BB. Arch Biochem Biophys 2005;438:111-118.
6. Edelberg JM, Lee SH, Kaur M, Tang L, Feirt NM, McCabe S et al. Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation 2002;105:608-613.
7. Hamid SA, Baxter GF. Adrenomedullin limits reperfusion injury in experimental myocardial infarction. Basic Res Cardiol 2005;100:387-396.
8. Su EJ, Cioffi CL, Stefansson S, Mittereder N, Garay M, Hreniuk D et al. Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization. Am J Physiol 2003;284:H1429-H1440.
9. Vogt AM, Htun P, Kluge A, Zimmermann R, Schaper W. Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion. Cardiovasc Res 1997;33:469-477.
10. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001;89:168-173.
11. Yoshida T, Maulik N, Ho YS, Alam J, Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 2001;103:1695-1701.
12. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-1081.
13. Kozak M. An analysis of 50-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987;15:8125-8148.
14. Filipeanu CM, Zhou F, Claycomb WC, Wu G. Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. J Biol Chem 2004;279:41077-41084.
15. Sun B, Sun Z, Jin Q, Chen X. CO-releasing molecules (CORM-2) liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice. Int J Biol Sci 2008;4:176-183.
16. Ruusalepp A, Czibik G, Flatebo T, Vaage J, Valen G. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases. Basic Res Cardiol 2007;102:318- 326.
17. Zhang W, Contag PR, Hardy J, Zhao H, Vreman HJ, Hajdena-Dawson M et al. Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med 2002;80:655-664.
18. Rizzuto G, Cappelletti M, Maione D, Savino R, Lazzaro D, Costa P et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999;96:6417- 6422.
19. Gronevik E, von Steyern FV, Kalhovde JM, Tjelle TE, Mathiesen I. Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle. J Gene Med 2005;7:218-227.
20. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ, Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol 1996;271:H1132-H1138.
21. Morioka I, Wong RJ, Abate A, Vreman HJ, Contag CH, Stevenson DK. Systemic effects of orally-administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice. Pediatr Res 2006;59:667-672.
22. Islam T, McConnell R, Gauderman WJ, Avol E, Peters JM, Gilliland FD. Ozone, oxidant defence genes, and risk of asthma during adolescence. Am J Respir Crit Care Med 2008;177:388-395.
23. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol 2005;289:H542-H548.
24. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002;105:602-607.
25. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol 2000;278:H643-H651.
26. Fujimoto H, Ohno M, Ayabe S, Kobayashi H, Ishizaka N, Kimura H et al. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 2004;24:1848-1853.
27. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95:2979-2984.